Phase 3 ACHIEVE-1 trial results for orforglipron, as discussed by Rosenstock and colleagues, demonstrated that this once-daily oral small molecule GLP-1 achieved statistically significant reductions in HbA1c (1.3% to 1.6% from a baseline of 8.0%) compared to placebo in adults with type 2 diabetes
Essentially, people don't feel the effects of alcohol as intensely if they're taking a GLP-1 med, researchers said
Removing excess breast tissue and skin folds improves chest contour, making it more masculine and proportionate, and alleviates physical discomfort from sagging skin
Expression and cellular localization of hepcidin mRNA and protein in normal rat brain
As an experimental triple receptor agonist that targets the GLP-1, GIP, and glucagon pathways, retatrutide has gotten a lot of attention for its possible use in studying glucose metabolism, weight control, and other metabolic processes